ROLE OF GENOTYPING FEATURES IN THE DEVELOPMENT OF RECURRENT VULVOVAGINAL CANDIDIASIS AND THERAPY TACTICS
Relevance: According to the literature, Vulvovaginal candidiasis (VVC) is diagnosed in 75% of women during life, and in 5-8% of women its recurrent course is developed (four or more episodes of exacerbation during 12 months). Recurrent vulvovaginal candidiasis (RVVC) is often observed in the presenc...
Main Authors: | S. M. Pogosyan, E. A. Mezhevitinova, A. E. Donnikov, V. V. Muravyova, P. R. Abakarova, Y. S. Khlebkova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2017-10-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/2002 |
Similar Items
-
Use of fluconazole in women of reproductive age with vulvovaginal candidiasis
by: E. A. Mezhevitinova, et al.
Published: (2018-09-01) -
The profile of the expression of the immune response genes in the vagina of women in the complex therapy of recurrent vulvovaginal candidiasis
by: Sh M Pogosyan, et al.
Published: (2017-06-01) -
Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
by: Gai Ge, et al.
Published: (2022-07-01) -
Genetic predisposition to a recurrent course of vulvovaginal candidiasis
by: Sh M Pogosyan, et al.
Published: (2017-08-01) -
Vulvovaginal Candidiasis: A Current Understanding and Burning Questions
by: Hubertine M.E. Willems, et al.
Published: (2020-02-01)